Publications by authors named "David Serisier"

Claim this Profile
B
Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis.
Michael A Barras, David Serisier, Stefanie Hennig, Katrina Jess, Ross L G Norris

Antimicrob Agents Chemother· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.
Alice C-H Chen, Megan L Martin, Rohan Lourie, Geraint B Rogers, Lucy D Burr, David J Serisier

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Republished: Respiratory microbiota: addressing clinical questions, informing clinical practice.
Geraint B Rogers, Dominick Shaw, Robyn L Marsh, Mary P Carroll, David J Serisier

Postgrad Med J· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
Steven L Taylor, Geraint B Rogers, Alice C-H Chen, Lucy D Burr, Michael A McGuckin, David J Serisier

Ann Am Thorac Soc· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory microbiota: addressing clinical questions, informing clinical practice.
Geraint B Rogers, Dominick Shaw, Robyn L Marsh, Mary P Carroll, David J Serisier

Thorax· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predominant pathogen competition and core microbiota divergence in chronic airway infection.
Geraint B Rogers, Christopher J van der Gast, David J Serisier

ISME J· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Geraint B Rogers, Kenneth D Bruce, Megan L Martin, Lucy D Burr, David J Serisier

Lancet Respir Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
Geraint B Rogers, Nur Masirah M Zain, Kenneth D Bruce, Lucy D Burr, Alice C Chen, David J Serisier

Ann Am Thorac Soc· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evidence base for non-CF bronchiectasis is finally evolving.
David J Serisier

Respirology· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suspected acute exacerbation of idiopathic pulmonary fibrosis associated with interferon alpha therapy for hepatitis C: case report.
Victoria Yee-May Ling, Marianne Mortimore, David J Serisier

Springerplus· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.
David J Serisier, Diana Bilton, Anthony De Soyza, Philip J Thompson, John Kolbe

Thorax· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
Geraint B Rogers, Christopher J van der Gast, Leah Cuthbertson, Serena K Thomson, Kenneth D Bruce, David J Serisier

Thorax· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases.
David J Serisier

Lancet Respir Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
David J Serisier, Megan L Martin, Michael A McGuckin, Rohan Lourie, Alice C Chen

JAMA· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia.
David J Serisier, Sophie Williams, Simon D Bowler

Respirology· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single maintenance and reliever therapy.
Simon Bowler, David Serisier

Thorax· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.
Geraint B Rogers, Stuart Skelton, David J Serisier, Christopher J van der Gast, Kenneth D Bruce

J Clin Microbiol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum.
David J Serisier, Mary P Carroll, Janis K Shute, Simon A Young

Respir Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a simple educational intervention on the hospital management of community-acquired pneumonia.
David J Serisier, Simon D Bowler

Respirology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of albuterol on maximal exercise capacity in cystic fibrosis.
David J Serisier, Andrew D Coates, Simon D Bowler

Chest· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nocardia paucivorans--a cause of disseminated nocardiosis.
Timothy James Gray, David J Serisier, Christopher M Gilpin, Christopher Coulter, Simon J Bowler

J Infect· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frozen section of pleural biopsies at medical thoracoscopy assists in correctly identifying benign disease.
David Fielding, Peter Hopkins, David Serisier

Respirology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial activity in cystic fibrosis lung infections.
Geraint B Rogers, Mary P Carroll, David J Serisier, Peter M Hockey, Valia Kehagia

Respir Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolid.
David J Serisier, Graeme Jones, Mary Carroll

J Cyst Fibros· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis.
David J Serisier, Graeme Jones, Andrew Tuck, Gary Connett, Mary P Carroll

Pediatr Pulmonol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis